Last reviewed · How we verify
NCT07367256
Using Virtual Reality to Improve Emotion Understanding in Children With Autism
NA trial testing Oculus intervention in Autism in 30 participants. Currently enrolling.
30 June 2026
Quick facts
| Lead sponsor | Istituto per la Ricerca e l'Innovazione Biomedica |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 2 February 2026 |
| Primary completion | 30 June 2026 |
| Estimated completion | 31 July 2026 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Oculus intervention
- Traditional intervention
Conditions studied
- Autism — all drugs for Autism →
- Autism Disorder — all drugs for Autism Disorder →
Sponsor
Istituto per la Ricerca e l'Innovazione Biomedica — full company profile →
Who can join
Adults 7 to 10, any sex, with Autism or Autism Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Autism Spectrum Disorders (ASD) are neurodevelopmental conditions characterized by difficulties in social interaction, communication, and in understanding one's own and others' mental and emotional states. In particular, skills related to the recognition, understanding, and regulation of emotions represent a significant area of vulnerability in children with high-functioning ASD, with important consequences for social and relational functioning. The present study aims to evaluate the effectiveness of an intervention protocol designed to enhance socio-emotional understanding, with a specific focus on the recognition of basic and complex emotions, the expansion of emotional vocabulary, the association between situations, thoughts, and emotions, and the differentiation between thoughts and emotions. Furthermore, the study seeks to investigate the role of immersive technology (Oculus) as a potential facilitator of emotional learning compared to a traditional intervention approach. The sample will consist of children with a diagnosis of high-functioning ASD, aged between 7 and 10 years, with sentence-level language abilities, the capacity to narrate non-present events, and an intellectual quotient above 80 (assessed using the Griffiths Scales or the WISC-IV). Participants will be divided into two groups: an experimental group (OCULUS), which will receive the intervention mediated by the use of Oculus technology, and a control group which will undergo the same protocol without technological support.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07367256
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Autism
Currently open trials in the same condition.
- NCT06853665 — The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine · Phase 4 · recruiting
- NCT06523387 — Online Pivotal Response Treatment Training in Autism Spectrum Disorder · NA · recruiting
- NCT07304440 — Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study · Phase 1, PHASE2 · recruiting
- NCT07403396 — Static Balance Assessment in Children With ASD Using VRRS · recruiting
- NCT07315867 — Better Social, Emotional Communication, Healthy Relationship and ASD Accommodation Skills: Emotional Intelligence ("EQ") · NA · recruiting
Other Istituto per la Ricerca e l'Innovazione Biomedica trials
Trials by the same sponsor.
- NCT07403396 — Static Balance Assessment in Children With ASD Using VRRS · recruiting
- NCT07456475 — Metaverse Applications in Clinical Neurorehabiliation: Device Feasibility · NA · active not recruiting
- NCT06872229 — The Impact of Sensory Integration on Attention in Autism · recruiting
- NCT06799962 — AI and VR Devices for Eating Behavior Rehabilitation · NA · recruiting
- NCT06462638 — COntact RElationship in Neonatal Intensive Care Unit · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07367256 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istituto per la Ricerca e l'Innovazione Biomedica
- Last refreshed: 26 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07367256.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing